Capricor Therapeutics | CAPR - Net Income


Capricor Therapeutics reported $-30.17M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Bioline Rx USD -3.03M 1.42M Jun/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 8.78B 884.9M Sep/2026
Cytokinetics USD -190.07M 8.69M Sep/2026
Geron USD 1.35M 18.03M Sep/2026
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
J&J USD 210M 5.32B Sep/2026
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Prothena USD -18.58M 51.3M Jun/2026
PTC Therapeutics USD 83.5M 86.3M Jun/2026
Sarepta Therapeutics USD -28.46M 23.57M Sep/2026